rss
Arch Dis Child 2005;90:985-986 doi:10.1136/adc.2004.061598
  • Letter

Dapsone therapy for Henoch-Schönlein purpura: a case series

  1. H Iqbal,
  2. A Evans
  1. Queen Elizabeth Hospital, London, UK
  1. Correspondence to:
    Dr H Iqbal
    Department of Paediatrics, Queen Elizabeth Hospital, Stadium Road, Woolwich, London SE18 4QH, UK; humaitiscali.co.uk

    Henoch-Schönlein purpura (HSP), first recognised by Heberden in 1801, is a systemic, IgA mediated vasculitis of small vessels that is usually self-limiting but may progress to gastrointestinal bleeding, intussusception, and nephropathy. A third of patients will experience recurrences.1 Currently treatment is confined to rest, analgesia, and steroids for refractory abdominal pain,2 and immunosuppressants for complications, especially renal disease. Original reports, predominantly in adults, show that the symptoms of purpuric rash, abdominal pain, and arthritis in HSP respond to treatment with dapsone.3–5 …

    [Full text of this article]

    Responses to this article

    • Comment on: Dapsone therapy for Henoch-Schonlein purpura: a case series
      • Jae Seung Lee,
      • Jae Il Shin, Ki Seop Chung
      ADC published online January 3, 2006

    This Article

    1. Extract
    2. Full text
    3. PDF

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

    ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics

    Show me all >>